Pathologically examining a minimum of three lymph nodes could better determine node negativity in patients with non-metastatic chromophobe renal cell carcinoma-Reference-Cited by-同舟云学术

Pathologically examining a minimum of three lymph nodes could better determine node negativity in patients with non-metastatic chromophobe renal cell carcinoma

Published:2018-08-18 Issue:10 Volume:48 Page:942-949
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Dong Fan¹,Xu Liqi²,Peng Xiaoqiong¹,Xu Tianyuan³,Shen Yifan¹,Gao Fengbin⁴,Wang Xianjin¹,Zhang Xiaohua¹,Chen Shanwen¹,Zhang Minguang¹,Zhong Shan¹,Ding Qiang¹

Affiliation:

1. Department of Urology, Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai

2. Department of Urology, No.113 Hospital of PLA, Ningbo, Zhejiang

3. Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai

4. Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Funder

National Natural Science Foundation of China

National Basic Research Program of China

Natural Science Foundation of Shanghai

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/48/10/942/26001182/hyy121.pdf

Reference28 articles.

1. The Heidelberg classification of renal cell tumours;Kovacs;J Pathol,1997

2. Renal cancer;Capitanio;Lancet,2016

3. Differences in overall and cancer-specific survival of patients presenting with chromophobe versus clear cell renal cell carcinoma: a propensity score matched analysis;Frees;Urology,2016

4. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma;Beck;Ann Surg Oncol,2004

5. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma;Blute;J Urol,2004